# Rocky Mountain Chocolate Factory, Inc.: financial statements, quarterly

RMCF · Nasdaq · CIK 1616262 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Feb 28

Pages: [Overview](/companies/rmcf.md) · [Financials](/companies/rmcf/financials.md) · [Filings](/companies/rmcf/filings.md) · [Insiders](/companies/rmcf/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rmcf/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2024 (2023-11-30) | Q4 FY2024 (2024-02-29) | Q1 FY2025 (2024-05-31) | Q2 FY2025 (2024-08-31) | Q3 FY2025 (2024-11-30) | Q4 FY2025 (2025-02-28) | Q1 FY2026 (2025-05-31) | Q2 FY2026 (2025-08-31) | Q3 FY2026 (2025-11-30) | Q4 FY2026 (2026-02-28) | Q1 FY2027 (2026-05-31) | Q2 FY2027 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [7,697](/filings/0000950170-25-005495.md) | [7,260 d](/filings/0001193125-26-248296.md) | [6,407](/filings/0000950170-25-095893.md) | [6,380](/filings/0001193125-25-239065.md) | [7,893](/filings/0001193125-26-011914.md) | [8,899 d](/filings/0001193125-26-248296.md) | [6,373](/filings/0001193125-26-303159.md) | [6,823](/filings/0001193125-26-425389.md) | [7,543](/filings/0001193125-26-011914.md) | [6,758 d](/filings/0001193125-26-248296.md) | [6,113](/filings/0001193125-26-303159.md) | [6,652](/filings/0001193125-26-425389.md) |
| Cost of revenue | $k | [5,769](/filings/0000950170-25-005495.md) | [5,497 d](/filings/0001193125-26-248296.md) | [5,586](/filings/0000950170-25-095893.md) | [4,350](/filings/0001193125-25-239065.md) | [6,044](/filings/0001193125-26-011914.md) | [7,936 d](/filings/0001193125-26-248296.md) | [4,392](/filings/0001193125-26-303159.md) | [5,216](/filings/0001193125-26-425389.md) | [4,979](/filings/0001193125-26-011914.md) | [6,056 d](/filings/0001193125-26-248296.md) | [4,702](/filings/0001193125-26-303159.md) | [4,887](/filings/0001193125-26-425389.md) |
| Gross profit | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $k | [(776)](/filings/0000950170-25-005495.md) | [(1,575) d](/filings/0001193125-26-248296.md) | [(1,630)](/filings/0000950170-25-095893.md) | [(914)](/filings/0001193125-25-239065.md) | [(700)](/filings/0001193125-26-011914.md) | [(2,698) d](/filings/0001193125-26-248296.md) | [(145)](/filings/0001193125-26-303159.md) | [(479)](/filings/0001193125-26-425389.md) | [82.0](/filings/0001193125-26-011914.md) | [(3,045) d](/filings/0001193125-26-248296.md) | [(1,006)](/filings/0001193125-26-303159.md) | [(1,085)](/filings/0001193125-26-425389.md) |
| Interest expense | $k | [11.0](/filings/0000950170-25-005495.md) | [29.0 d](/filings/0001193125-26-248296.md) | [35.0](/filings/0000950170-25-095893.md) | [63.0](/filings/0001193125-25-239065.md) | [160](/filings/0001193125-26-011914.md) | [196 d](/filings/0001193125-26-248296.md) | [188](/filings/0001193125-26-303159.md) | [190](/filings/0001193125-26-425389.md) | [243](/filings/0001193125-26-011914.md) | [219 d](/filings/0001193125-26-248296.md) | [208](/filings/0001193125-26-303159.md) | [211](/filings/0001193125-26-425389.md) |
| Income tax | $k | [0.0](/filings/0000950170-25-005495.md) | [0.0 d](/filings/0001193125-26-248296.md) | [0.0](/filings/0000950170-25-095893.md) | [0.0](/filings/0001193125-25-239065.md) | [0.0](/filings/0001193125-26-011914.md) | [0.0 d](/filings/0001193125-26-248296.md) | [0.0](/filings/0001193125-26-303159.md) | [0.0](/filings/0001193125-26-425389.md) | [0.0](/filings/0001193125-26-011914.md) | [187 d](/filings/0001193125-26-248296.md) | [0.0](/filings/0001193125-26-303159.md) | [0.0](/filings/0001193125-26-425389.md) |
| Net income | $k | [(757)](/filings/0000950170-25-005495.md) | [(1,593) d](/filings/0001193125-26-248296.md) | [(1,658)](/filings/0001193125-26-011914.md) | [(722)](/filings/0001193125-26-011914.md) | [(847)](/filings/0001193125-26-011914.md) | [(2,895) d](/filings/0001193125-26-248296.md) | [(324)](/filings/0001193125-26-425389.md) | [(662)](/filings/0001193125-26-425389.md) | [(155)](/filings/0001193125-26-011914.md) | [(3,419) d](/filings/0001193125-26-248296.md) | [(1,168)](/filings/0001193125-26-425389.md) | [(1,281)](/filings/0001193125-26-425389.md) |
| Diluted EPS | $ per share | [(0.12)](/filings/0000950170-25-005495.md) | not reported | [(0.26)](/filings/0000950170-25-095893.md) | [(0.11)](/filings/0001193125-25-239065.md) | [(0.11)](/filings/0001193125-26-011914.md) | not reported | [(0.04)](/filings/0001193125-26-303159.md) | [(0.09)](/filings/0001193125-26-425389.md) | [(0.02)](/filings/0001193125-26-011914.md) | not reported | [(0.12)](/filings/0001193125-26-303159.md) | [(0.14)](/filings/0001193125-26-425389.md) |
| Basic EPS | $ per share | [(0.12)](/filings/0000950170-25-005495.md) | not reported | [(0.26)](/filings/0000950170-25-095893.md) | [(0.11)](/filings/0001193125-25-239065.md) | [(0.11)](/filings/0001193125-26-011914.md) | not reported | [(0.04)](/filings/0001193125-26-303159.md) | [(0.09)](/filings/0001193125-26-425389.md) | [(0.02)](/filings/0001193125-26-011914.md) | not reported | [(0.12)](/filings/0001193125-26-303159.md) | [(0.14)](/filings/0001193125-26-425389.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2024 (2023-11-30) | FY2024 (2024-02-29) | Q1 FY2025 (2024-05-31) | Q2 FY2025 (2024-08-31) | Q3 FY2025 (2024-11-30) | FY2025 (2025-02-28) | Q1 FY2026 (2025-05-31) | Q2 FY2026 (2025-08-31) | Q3 FY2026 (2025-11-30) | FY2026 (2026-02-28) | Q1 FY2027 (2026-05-31) | Q2 FY2027 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [2.1](/filings/0001437749-24-001395.md) | [2.1](/filings/0000950170-25-088556.md) | [0.6](/filings/0000950170-24-083642.md) | [1.0](/filings/0000950170-24-114671.md) | [1.1](/filings/0000950170-25-005495.md) | [0.7](/filings/0001193125-26-248296.md) | [0.9](/filings/0000950170-25-095893.md) | [2.0](/filings/0001193125-25-239065.md) | [0.6](/filings/0001193125-26-011914.md) | [1.2](/filings/0001193125-26-425389.md) | [0.6](/filings/0001193125-26-303159.md) | [0.4](/filings/0001193125-26-425389.md) |
| Current assets | $m | [10.1](/filings/0001437749-24-001395.md) | [9.6](/filings/0000950170-25-088556.md) | [9.2](/filings/0000950170-24-083642.md) | [11.0](/filings/0000950170-24-114671.md) | [11.3](/filings/0000950170-25-005495.md) | [9.2](/filings/0001193125-26-248296.md) | [8.4](/filings/0000950170-25-095893.md) | [10.2](/filings/0001193125-25-239065.md) | [9.1](/filings/0001193125-26-011914.md) | [8.8](/filings/0001193125-26-425389.md) | [7.5](/filings/0001193125-26-303159.md) | [7.1](/filings/0001193125-26-425389.md) |
| Total assets | $m | [21.3](/filings/0000950170-25-005495.md) | [20.6](/filings/0001193125-26-248296.md) | [19.0](/filings/0000950170-25-095893.md) | [21.1](/filings/0001193125-25-239065.md) | [21.6](/filings/0001193125-26-011914.md) | [21.2](/filings/0001193125-26-248296.md) | [20.1](/filings/0001193125-26-303159.md) | [22.3](/filings/0001193125-26-425389.md) | [20.7](/filings/0001193125-26-011914.md) | [20.2](/filings/0001193125-26-425389.md) | [19.3](/filings/0001193125-26-303159.md) | [18.8](/filings/0001193125-26-425389.md) |
| Current liabilities | $m | [7.1](/filings/0001437749-24-001395.md) | [8.1](/filings/0000950170-25-088556.md) | [8.4](/filings/0000950170-24-083642.md) | [8.9](/filings/0000950170-24-114671.md) | [4.3](/filings/0000950170-25-005495.md) | [6.9](/filings/0001193125-26-248296.md) | [6.2](/filings/0000950170-25-095893.md) | [6.7](/filings/0001193125-25-239065.md) | [5.5](/filings/0001193125-26-011914.md) | [6.6](/filings/0001193125-26-425389.md) | [6.7](/filings/0001193125-26-303159.md) | [13.6](/filings/0001193125-26-425389.md) |
| Total liabilities | $m | not reported | [9.9](/filings/0000950170-25-088556.md) | [10.0](/filings/0000950170-24-083642.md) | [10.6](/filings/0000950170-24-114671.md) | [11.8](/filings/0000950170-25-005495.md) | [14.2](/filings/0001193125-26-248296.md) | [13.4](/filings/0000950170-25-095893.md) | [16.1](/filings/0001193125-25-239065.md) | [14.7](/filings/0001193125-26-011914.md) | [15.0](/filings/0001193125-26-425389.md) | [15.1](/filings/0001193125-26-303159.md) | [15.8](/filings/0001193125-26-425389.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.3](/filings/0001193125-26-425389.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [12.3](/filings/0000950170-25-005495.md) | [10.6](/filings/0001193125-26-248296.md) | [9.0](/filings/0001193125-26-011914.md) | [10.5](/filings/0001193125-26-011914.md) | [9.8](/filings/0001193125-26-011914.md) | [7.0](/filings/0001193125-26-425389.md) | [6.7](/filings/0001193125-26-425389.md) | [6.1](/filings/0001193125-26-425389.md) | [6.0](/filings/0001193125-26-011914.md) | [5.2](/filings/0001193125-26-425389.md) | [4.1](/filings/0001193125-26-425389.md) | [3.0](/filings/0001193125-26-425389.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2024 (2023-11-30) | Q4 FY2024 (2024-02-29) | Q1 FY2025 (2024-05-31) | Q2 FY2025 (2024-08-31) | Q3 FY2025 (2024-11-30) | Q4 FY2025 (2025-02-28) | Q1 FY2026 (2025-05-31) | Q2 FY2026 (2025-08-31) | Q3 FY2026 (2025-11-30) | Q4 FY2026 (2026-02-28) | Q1 FY2027 (2026-05-31) | Q2 FY2027 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(1,598) d](/filings/0000950170-25-005495.md) | [129 d](/filings/0001193125-26-248296.md) | [(2,157)](/filings/0000950170-25-095893.md) | [(3,513) d](/filings/0001193125-25-239065.md) | [(2,119) d](/filings/0001193125-26-011914.md) | [1,194 d](/filings/0001193125-26-248296.md) | [350](/filings/0001193125-26-303159.md) | [(488) d](/filings/0001193125-26-425389.md) | [(1,240) d](/filings/0001193125-26-011914.md) | [(432) d](/filings/0001193125-26-248296.md) | [(345)](/filings/0001193125-26-303159.md) | [(153) d](/filings/0001193125-26-425389.md) |
| Capital expenditure | $k | [1,284](/filings/0001437749-24-001395.md) | [400 d](/filings/0001193125-26-248296.md) | [417](/filings/0000950170-25-095893.md) | [1,117 d](/filings/0001193125-25-239065.md) | [614 d](/filings/0001193125-26-011914.md) | [1,614 d](/filings/0001193125-26-248296.md) | [168](/filings/0001193125-26-303159.md) | [56.0 d](/filings/0001193125-26-425389.md) | [38.0 d](/filings/0001193125-26-011914.md) | [307 d](/filings/0001193125-26-248296.md) | [259](/filings/0001193125-26-303159.md) | [(15.0) d](/filings/0001193125-26-425389.md) |
| Dividends paid | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2023 (2022-11-30) | Q1 FY2024 (2023-05-31) | Q2 FY2024 (2023-08-31) | Q3 FY2024 (2023-11-30) | Q1 FY2025 (2024-05-31) | Q2 FY2025 (2024-08-31) | Q3 FY2025 (2024-11-30) | Q1 FY2026 (2025-05-31) | Q2 FY2026 (2025-08-31) | Q3 FY2026 (2025-11-30) | Q1 FY2027 (2026-05-31) | Q2 FY2027 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [6,227](/filings/0001437749-24-001395.md) | [6,277](/filings/0000950170-24-083642.md) | [6,239](/filings/0000950170-24-114671.md) | [6,302](/filings/0000950170-25-005495.md) | [6,322](/filings/0000950170-25-095893.md) | [6,687](/filings/0001193125-25-239065.md) | [7,644](/filings/0001193125-26-011914.md) | [7,742](/filings/0001193125-26-303159.md) | [7,786](/filings/0001193125-26-425389.md) | [7,799](/filings/0001193125-26-011914.md) | [9,390](/filings/0001193125-26-303159.md) | [9,447](/filings/0001193125-26-425389.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 9,601,236 at 2026-10-08, from the cover of the [10-Q filed 2026-10-19](/filings/0001193125-26-425389.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. No prices; not investment advice.